Caption Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.7M Buy
325,000
+150,000
+86% +$8.74M 0.12% 191
2025
Q4
$9.44M Buy
175,000
+50,000
+40% +$2.41M 0.06% 346
2025
Q3
$5.64M Sell
125,000
-11,000
-8% -$514K 0.04% 450
2025
Q2
$6.3M Buy
136,000
+56,000
+70% +$2.75M 0.07% 335
2025
Q1
$4.88M Sell
80,000
-120,000
-60% -$6.99M 0.05% 403
2024
Q4
$11.3M Buy
200,000
+161,400
+418% +$9.02M 0.11% 165
2024
Q3
$2M Buy
+38,600
New +$1.81M 0.03% 556
2024
Q1
Sell
-50,000
Closed -$2.57M 1225
2023
Q4
$2.57M Sell
50,000
-448,500
-90% -$23.5M 0.03% 542
2023
Q3
$28.9M Sell
498,500
-200,000
-29% -$12.3M 0.45% 38
2023
Q2
$44.7M Buy
698,500
+200,000
+40% +$13.4M 0.79% 12
2023
Q1
$34.6M Sell
498,500
-45,000
-8% -$3.17M 0.67% 27
2022
Q4
$39.1M Buy
543,500
+493,500
+987% +$37.2M 0.61% 25
2022
Q3
$3.56M Hold
50,000
0.05% 455
2022
Q2
$3.85M Buy
50,000
+13,500
+37% +$1.03M 0.05% 444
2022
Q1
$2.67M Buy
+36,500
New +$2.45M 0.03% 653
2021
Q4
Sell
-300,000
Closed -$17.8M 1608
2021
Q3
$17.8M Buy
300,000
+172,000
+134% +$11.3M 0.2% 116
2021
Q2
$8.55M Buy
+128,000
New +$8.35M 0.11% 235
2019
Q2
Sell
-997,200
Closed -$47.6M 661
2019
Q1
$47.6M Buy
+997,200
New +$49.7M 2.62% 2
2018
Q1
Sell
-204,400
Closed -$12.5M 228
2017
Q4
$12.5M Buy
+204,400
New +$12.8M 1.3% 14

Other funds holding BMY

Caption Management's BMY Position: Q1 2026 in Review

Caption Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 537,700 shares — an estimated $31.3M sold.

Caption Management first reported a position in BMY in Q4 2017 and held it in 16 quarters. The position peaked at $29M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Caption Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 537,700 Bristol-Myers Squibb shares in Q1 2026, an estimated $31.3M.
  • Caption Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 16 quarters.
  • Caption Management's Bristol-Myers Squibb position peaked at $29M in Q4 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.